Cargando…

Simultaneous targeting of Eph receptors in glioblastoma

Eph tyrosine kinase receptors are frequently overexpressed and functional in many cancers, and they are attractive candidates for targeted therapy. Here, we analyzed the expression of Eph receptor A3, one of the most up-regulated factors in glioblastoma cells cultured under tumorsphere-forming condi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferluga, Sara, Tomé, Carla Maria Lema, Herpai, Denise Mazess, D'Agostino, Ralph, Debinski, Waldemar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312354/ https://www.ncbi.nlm.nih.gov/pubmed/27494882 http://dx.doi.org/10.18632/oncotarget.10978

Ejemplares similares

Drug Conjugates for Targeting Eph Receptors in Glioblastoma
por: Sharma, Puja, et al.
Publicado: (2020)

Multireceptor targeting of glioblastoma
por: Sharma, Puja, et al.
Publicado: (2020)

IL13RA2 targeted alpha particle therapy against glioblastomas
por: Sattiraju, Anirudh, et al.
Publicado: (2017)

Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
por: Rossmeisl, John H, et al.
Publicado: (2020)

Eph receptors as therapeutic targets in glioblastoma
por: Day, B W, et al.
Publicado: (2014)

The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment
por: Sanders, Stephanie, et al.
Publicado: (2021)

A Novel Extracellular Hsp90 Mediated Co-Receptor Function for LRP1 Regulates EphA2 Dependent Glioblastoma Cell Invasion
por: Gopal, Udhayakumar, et al.
Publicado: (2011)

Selective anti-tumor activity of the novel fluoropyrimidine polymer F10 towards G48a orthotopic GBM tumors
por: Gmeiner, William H., et al.
Publicado: (2013)

Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells
por: Kim, Teddy E., et al.
Publicado: (2021)

Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor
por: Renfrow, Jaclyn J., et al.
Publicado: (2020)

Receptor-Targeted Glial Brain Tumor Therapies
por: Sharma, Puja, et al.
Publicado: (2018)

Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma
por: Sanders, Stephanie, et al.
Publicado: (2020)

Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker
por: Sai, Kiran Kumar Solingapuram, et al.
Publicado: (2017)

Neurosurgical Techniques for Disruption of the Blood–Brain Barrier for Glioblastoma Treatment
por: Rodriguez, Analiz, et al.
Publicado: (2015)

Metal-Based Nanostructured Therapeutic Strategies for Glioblastoma Treatment—An Update
por: Gawel, Agata M., et al.
Publicado: (2022)

Eph receptors as oncotargets
por: Charmsaz, Sara, et al.
Publicado: (2017)

Antibody Targeting of Eph Receptors in Cancer
por: Janes, Peter W., et al.
Publicado: (2020)

Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4
por: Royet, Amélie, et al.
Publicado: (2017)

Roles of EphA2 Receptor in Angiogenesis Signaling Pathway of Glioblastoma Multiforme
por: Baharuddin, Wan Noor Ainun, et al.
Publicado: (2018)

Eph receptors and ephrins as targets for cancer therapy
por: Xi, Hong-Qing, et al.
Publicado: (2012)

Selection of a Novel Aptamer Against Vitronectin Using Capillary Electrophoresis and Next Generation Sequencing
por: Stuart, Christopher H, et al.
Publicado: (2016)

P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment
por: Mao, Chengqiong, et al.
Publicado: (2018)

Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine
por: Quinn, Bridget A., et al.
Publicado: (2016)

EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells
por: Dong, Xiao-Dong, et al.
Publicado: (2023)

Eph Receptors in Cancer
por: Arora, Sakshi, et al.
Publicado: (2023)

Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors
por: Janes, Peter W., et al.
Publicado: (2011)

Canine Butterfly Glioblastomas: A Neuroradiological Review
por: Rossmeisl, John H., et al.
Publicado: (2016)

The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis
por: Carpenter, Richard L., et al.
Publicado: (2015)

UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice
por: Festuccia, Claudio, et al.
Publicado: (2018)

miR-30 Disrupts Senescence and Promotes Cancer by Targeting both p16(INK4A) and DNA Damage Pathways
por: Su, Weijun, et al.
Publicado: (2018)

Identification and characterization of Nanobodies targeting the EphA4 receptor
por: Schoonaert, Lies, et al.
Publicado: (2017)

EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase
por: Wang, Shervin D., et al.
Publicado: (2012)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors
por: Debinski, Waldemar, et al.
Publicado: (2013)

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma
por: Offenhäuser, Carolin, et al.
Publicado: (2018)

The Role of the Eph Receptor Family in Tumorigenesis
por: Anderton, Meg, et al.
Publicado: (2021)

Eph Receptors and Ephrins in Retinal Diseases
por: Kaczmarek, Radoslaw, et al.
Publicado: (2021)

Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4
por: Stephenson, Sally-Anne, et al.
Publicado: (2015)

The putative tumor suppressor gene EphA7 is a novel BMI-1 target
por: Prost, Gaëlle, et al.
Publicado: (2016)

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dmd00bm11vlkchc94hrlg048oo